The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
申请公布号
HK1217694(A1)
申请公布日期
2017.01.20
申请号
HK20160105561
申请日期
2016.05.16
申请人
F. HOFFMANN-LA ROCHE AG
发明人
BILOTTA, Joseph Anthony;CHEN, Zhi;DING, Qingjie;ERICKSON, Shawn David;MERTZ, Eric;WEIKERT, Robert James